Dr. Lal PathLabs Limited (LALPATHLAB.NS)
INR 3018.6
(-0.67%)
INR 3018.6
(-0.67%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.57 Billion INR | 49.78% |
| 2022 | 2.38 Billion INR | -30.73% |
| 2021 | 3.44 Billion INR | 18.24% |
| 2020 | 2.91 Billion INR | 29.07% |
| 2019 | 2.25 Billion INR | 13.44% |
| 2018 | 1.99 Billion INR | 16.64% |
| 2017 | 1.7 Billion INR | 10.74% |
| 2016 | 1.54 Billion INR | 16.65% |
| 2015 | 1.32 Billion INR | 40.26% |
| 2014 | 942.44 Million INR | 18.42% |
| 2013 | 795.87 Million INR | 44.36% |
| 2012 | 551.32 Million INR | 23.3% |
| 2011 | 447.14 Million INR | 53.55% |
| 2010 | 291.2 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.29 Billion INR | 21.43% |
| 2024 Q1 | 1.06 Billion INR | 25.87% |
| 2023 Q1 | 826 Million INR | 45.68% |
| 2023 FY | 3.57 Billion INR | 49.78% |
| 2023 Q3 | 813 Million INR | -25.62% |
| 2023 Q4 | 845.35 Million INR | 3.98% |
| 2023 Q2 | 1.09 Billion INR | 32.32% |
| 2022 Q3 | 528 Million INR | -26.36% |
| 2022 Q1 | 577 Million INR | -5.92% |
| 2022 FY | 2.38 Billion INR | -30.73% |
| 2022 Q4 | 567 Million INR | 7.39% |
| 2022 Q2 | 717 Million INR | 24.26% |
| 2021 Q2 | 950 Million INR | -27.59% |
| 2021 FY | 3.44 Billion INR | 18.24% |
| 2021 Q3 | 573 Million INR | -39.68% |
| 2021 Q1 | 1.31 Billion INR | 57.27% |
| 2021 Q4 | 613.33 Million INR | 7.04% |
| 2020 Q2 | 853 Million INR | 200.35% |
| 2020 Q4 | 834.21 Million INR | -11.72% |
| 2020 FY | 2.91 Billion INR | 29.07% |
| 2020 Q1 | 284 Million INR | -12.73% |
| 2020 Q3 | 945 Million INR | 10.79% |
| 2019 FY | 2.25 Billion INR | 13.44% |
| 2019 Q4 | 325.41 Million INR | -39.85% |
| 2019 Q3 | 541 Million INR | -32.8% |
| 2019 Q2 | 805 Million INR | 36.9% |
| 2019 Q1 | 588 Million INR | 24.89% |
| 2018 Q4 | 470.8 Million INR | 2.79% |
| 2018 Q3 | 458 Million INR | -19.65% |
| 2018 Q2 | 570 Million INR | 15.38% |
| 2018 Q1 | 494 Million INR | 23.19% |
| 2018 FY | 1.99 Billion INR | 16.64% |
| 2017 Q2 | 506 Million INR | 14.74% |
| 2017 Q4 | 401 Million INR | 11.39% |
| 2017 FY | 1.7 Billion INR | 10.74% |
| 2017 Q3 | 360 Million INR | -28.85% |
| 2017 Q1 | 441 Million INR | 42.3% |
| 2016 Q4 | 309.9 Million INR | 0.39% |
| 2016 FY | 1.54 Billion INR | 16.65% |
| 2016 Q3 | 308.7 Million INR | -41.21% |
| 2016 Q2 | 525.1 Million INR | 31.87% |
| 2016 Q1 | 398.2 Million INR | 15.62% |
| 2015 Q4 | 344.4 Million INR | -43.37% |
| 2015 FY | 1.32 Billion INR | 40.26% |
| 2015 Q1 | 307.4 Million INR | 12.58% |
| 2015 Q2 | 61.9 Million INR | -79.86% |
| 2015 Q3 | 608.2 Million INR | 882.55% |
| 2014 Q3 | 226.6 Million INR | 0.0% |
| 2014 FY | 942.44 Million INR | 18.42% |
| 2014 Q4 | 273.04 Million INR | 20.49% |
| 2013 FY | 795.87 Million INR | 44.36% |
| 2012 FY | 551.32 Million INR | 23.3% |
| 2011 FY | 447.14 Million INR | 53.55% |
| 2010 FY | 291.2 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 568.37 Million INR | -529.405% |
| Metropolis Healthcare Limited | 1.27 Billion INR | -179.882% |
| Thyrocare Technologies Limited | 707.6 Million INR | -405.561% |
| Vijaya Diagnostic Centre Limited | 1.18 Billion INR | -201.06% |
| Vimta Labs Limited | 410.09 Million INR | -772.333% |